Form 4: Fortrea Holdings Inc. Officer Mark A. Morais Reports Stock Transactions
SEC Form 4
Chief Operating Officer Mark A. Morais of Fortrea Holdings Inc. reports the vesting and subsequent tax withholding of restricted stock units.
Summary
- On March 4, 2024, Mark A. Morais, Chief Operating Officer of Fortrea Holdings Inc., reported transactions involving the company's stock.
- Morais acquired 15,368 shares of common stock upon the vesting of restricted stock units (RSUs).
- Simultaneously, 4,450 shares were withheld by Fortrea to satisfy tax obligations related to the RSU vesting at a price of $36.7 per share.
- Following these transactions, Morais directly owns 18,406 shares of common stock and 74,654 RSUs.
- The RSUs were converted from Labcorp performance awards granted in 2021 and vested on March 4, 2024, according to the Employee Matters Agreement related to the Fortrea spin-off.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions, providing transparency to investors regarding the actions of company executives. It is a standard practice for publicly traded companies and their officers.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency in insider trading activities.
- Similar filings are made by officers and directors of companies like IQVIA, ICON, and PPD, all of which operate in the contract research organization (CRO) industry.
- The reporting requirements are governed by Section 16(a) of the Securities Exchange Act of 1934, ensuring a level playing field for all publicly traded companies.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and stock ownership.
- The tax withholding impacts the company's cash flow, although it is a standard practice.
Key Dates
| Date | Description |
|---|---|
| June 8, 2023 | Date of Power of Attorney execution. |
| December 31, 2023 | End of the three-year performance period for Labcorp performance awards. |
| March 4, 2024 | Date of RSU vesting and stock transactions. |
| March 6, 2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.